CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement Bridging the Gap Between Epigenetic and Genetic in PAH Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience Regional Heterogeneity in the Coronary Vascular Response in Women With Chest Pain and Nonobstructive Coronary Artery Disease The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors

Guideline2014 Jun 24;129(25 Suppl 2):S49-73.

JOURNAL:Circulation. Article Link

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Goff DC Jr, Lloyd-Jones DM, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Keywords: AHA Scientific Statements; biomarkers; cardiovascular disease; cholesterol; primary prevention; risk assessment; risk reduction behavior

Full Text PDF